CD8A and breast carcinoma: In a study of malignant breast cancer cells, tumor-derived extracellular vesicles could transport active TGF-β type II receptors (TβRII) to CD8+ T cells, thereby activating SMAD3 expression in CD8 T cells, ultimately leading to TEX and resulting in failure of immunotherapy (40).